GLP-1 Drugs Don't Make the Grade

Back

May 10, 2023

GLP-1 Drugs Don't Make the Grade

I wasn't going to do this post. I didn't want to talk about the Pharmamachine or its unethical influence in Medicine.

But I felt compelled. To protect those willing to listen. To challenge others to look closer and ask more questions.

The facts

  • All of the studies reported a calorie intake of 800 calories focused on WHOLE FOODS.
    1. They DID NOT allow processed carbohydrates, grains, sugar, or snacking
    2. They required 12-14 hours of fasting.
  • All of the studies reported that 50% of subjects had Nausea, Vomiting and Diarrhea.
    1. In people not on medications, we label the use of vomiting and laxatives a form of an eating disorder, so why is this "okay" in the studies? In real life?
    2. This is NOT FAT LOSS. it is literally water weight and messes up the balance of electrolytes in the body.
    3. It's causing anorexia: not wanting to eat due to nausea...
  • The France Study that included 3.67 Million people showed that 4% developed thyroid cancer when compared to the placebo. Because CANCER is Obviously allowable... (2)
  • Long Term, there are KNOWN factors that support calorie intake between 1200-1500 kcal and suggest that 800 kcal beyond 6 weeks is detrimental to LONG TERM HEALTH (3) (4) (5) as it reduces intake of required micronutrients.
    1. Long term very low calorie diets were also shown to slow the metabolism significantly

The Reported side effects

  1. Biliary and gallbladder dysfunction/disease (1)
  2. Gastroparesis
  3. Thyroid Cancer (5% affected)
  4. Permanent ruin of metabolic hormones
  5. Nausea/Vomiting/Diarrhea (more than 50% affected)
  6. Increased Resting Heart Rate
  7. Dizziness
  8. Headaches
  9. Increased Risk for Infections.
  10. Acute pancreatitis and Pancreatic Cancer (2%)

Side Effects I've been contacted about: Debilitating joint pain, muscle pain and Rhabdomyolysis.

My programs focus on Resetting metabolism without drugs that destroy your health.

If you're interested in learning more, schedule a consultation by clicking on the Image below


1. Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary DiseasesA Systematic Review and Meta-analysis of Randomized Clinical Trials

Liyun He, MM1; Jialu Wang, MM1; Fan Ping, MD1; et al

2. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer

Julien Bezin 1 2, Amandine Gouverneur 1 2, Marine Pénichon 2, Clément Mathieu 2, Renaud Garrel 3, Dominique Hillaire-Buys 4, Antoine Pariente 1 2, Jean-Luc Faillie 4 5

3. Wing, R.R.; Marcus, M.D.; Salata, R.; Epstein, L.H.; Miaskiewicz, S.; Blair, E.H. Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects. Arch. Intern. Med. 1991, 151, 1334–1340. [Google Scholar]

4. Vallejo EA. Hunger diet on alternate days in the nutrition of the aged. Prensa Med Argent. 1957;44:119–120. (In Spanish). [PubMed] [Google Scholar]

5. Stunkard AJ. Nutrition, longevity and obesity. In: Rockstein M, editor; Sussman ML, editor. Nutrition, Aging and Obesity. New York: Academic Press; 1976. pp. 253–284. [Google Scholar]